Pregabalin-induced neuroprotection and gait improvement in dystrophic MDX mice

被引:3
|
作者
Assis, Alex Dias [1 ]
Chiarotto, Gabriela Bortolanca [1 ,2 ]
Simoes, Gustavo Ferreira [1 ]
Rodrigues Oliveira, Alexandre Leite [1 ]
机构
[1] Univ Campinas UNICAMP, Lab Nerve Regenerat, Cidade Univ Zeferino Vaz,Rua Monteiro Lobato 255, BR-13083970 Campinas, SP, Brazil
[2] Univ Ctr Herminio Ometto Fdn FHO, Biomed Sci Grad Program, Araras, SP, Brazil
基金
巴西圣保罗研究基金会;
关键词
DMD; Therapy; MDX; Nervous system; Pregabalin; DUCHENNE MUSCULAR-DYSTROPHY; SPINAL-CORD-INJURY; NEUROMUSCULAR-JUNCTION; SKELETAL-MUSCLE; NEUROPATHIC PAIN; PURKINJE-CELLS; NERVE; CALCIUM; DEGENERATION; REGENERATION;
D O I
10.1016/j.mcn.2021.103632
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Duchenne muscular dystrophy (DMD) is a genetic disease linked to the X chromosome induced by mutations in the dystrophin gene. Neuroprotective drugs, such as pregabalin (PGB), can improve motor function through the modulation of excitatory synapses, together with anti-apoptotic and anti-inflammatory effects. The present work studied the effects of PGB in the preservation of dystrophic peripheral nerves, allowing motor improvements in MDX mice. Five weeks old MDX and C57BL/10 mice were treated with PGB (30 mg/kg/day, i.p.) or vehicle, for 28 consecutive days. The mice were sacrificed on the 9th week, the sciatic nerves were dissected out and processed for immunohistochemistry and qRT-PCR, for evaluating the expression of proteins and gene transcripts related to neuronal activity and Schwann cell function. The lumbar spinal cords were also processed for qRT-PCR to evaluate the expression of neurotrophic factors and pro- and anti-inflammatory cytokines. Cranial tibial muscles were dissected out for endplate evaluation with alpha-bungarotoxin. The recovery of motor function was monitored throughout the treatment, using a spontaneous walking track test (Catwalk system) and a forced locomotion test (Rotarod). The results showed that treatment with PGB reduced the retrograde effects of muscle degeneration/regeneration on the nervous system from the 5th to the 9th week in MDX mice. Thus, PGB induced protein expression in neurons and Schwann cells, protecting myelinated fibers. In turn, better axonal morphology and close-to-normal motor endplates were observed. Indeed, such effects resulted in improved motor coordination of dystrophic animals. We believe that treatment with PGB improved the balance between excitatory and inhibitory inputs to spinal motoneurons, increasing motor control. In addition, PGB enhanced peripheral nerve homeostasis, by positively affecting Schwann cells. In general, the present results indicate that pregabalin is effective in protecting the PNS during the development of DMD, improving motor coordination, indicating possible translation to the clinic.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Pregabalin-induced generalized myoclonic status epilepticus in patients with chronic pain
    Knake, S.
    Klein, K. M.
    Hattemer, K.
    Wellek, A.
    Oertel, W. H.
    Hamer, H. M.
    Rosenow, F.
    EPILEPSY & BEHAVIOR, 2007, 11 (03) : 471 - 473
  • [32] Photobiomodulation Therapy for Attenuating the Dystrophic Phenotype of Mdx Mice
    Macedo, Aline Barbosa
    Mizobuti, Daniela Sayuri
    Hermes, Tulio de Almeida
    Mancio, Rafael Dias
    Pertille, Adriana
    Kido, Larissa Akemi
    Alves Cagnon, Valeria Helena
    Minatel, Elaine
    PHOTOCHEMISTRY AND PHOTOBIOLOGY, 2020, 96 (01) : 200 - 207
  • [33] Sarcolipin haploinsufficiency prevents dystrophic cardiomyopathy in mdx mice
    Mareedu, Satvik
    Pachon, Ronald
    Thilagavathi, Jayapalraj
    Fefelova, Nadezhda
    Balakrishnan, Rekha
    Niranjan, Nandita
    Xie, Lai-Hua
    Babu, Gopal J.
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2021, 320 (01): : H200 - H210
  • [34] THE PITUITARY-MUSCLE AXIS IN MDX DYSTROPHIC MICE
    ANDERSON, JE
    LIU, L
    KARDAMI, E
    MURPHY, LJ
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 1994, 123 (1-2) : 80 - 87
  • [35] ADAM 12 alleviates the pathology of the MDX dystrophic mice
    Kronqvist, P
    Kawaguchi, N
    Frölich, C
    Xu, X
    Schroder, HD
    Mogdaszadeh, B
    Nielsen, FC
    Albrechtsen, R
    Engvall, E
    Wewer, UM
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2002, 199 : S65 - S65
  • [36] Erythropoietin reduces the expression of myostatin in mdx dystrophic mice
    Feder, D.
    Rugollini, M.
    Santomauro, A., Jr.
    Oliveira, L. P.
    Lioi, V. P.
    dos Santos, R.
    Ferreira, L. G.
    Nunes, M. T.
    Carvalho, M. H.
    Delgado, P. O.
    Carvalho, A. A. S.
    Fonseca, F. L. A.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2014, 47 (11) : 966 - 971
  • [37] ANALYSIS OF PERISTALTIC REFLEX IN YOUNG MDX DYSTROPHIC MICE
    MANCINELLI, R
    TONALI, P
    SERVIDEI, S
    AZZENA, GB
    NEUROSCIENCE LETTERS, 1995, 192 (01) : 57 - 60
  • [38] Tamoxifen increases muscular strength of the mdx dystrophic mice
    Feder, D
    Cavalsan, A
    Vasquez, RF
    Lin, RC
    Zyngier, SB
    Velloso, FJ
    Fogaca, LL
    Silva, HC
    Vainzof, M
    NEUROMUSCULAR DISORDERS, 2005, 15 (9-10) : 713 - 714
  • [39] Beneficial effect of pentoxifylline on dystrophic progression of mdx mice
    De Luca, A.
    Burdi, R.
    Fraysse, B.
    Rolland, J. F.
    Didonna, M. P.
    Giannuzzi, V.
    Liantonio, A.
    Camerino, C.
    Zallone, A.
    Ferro, P.
    Andreetta, F.
    Confalonieri, P.
    Conte, Camerino D.
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 138 - 138
  • [40] In vivo biolistic technique in control and mdx dystrophic mice
    Ausenda, CD
    Bresolin, N
    DeLiso, A
    DAngelo, MG
    Moggio, M
    DelBo, R
    Gallanti, A
    Comi, GP
    Torrente, Y
    Bordoni, A
    Scarlato, G
    MUSCLE & NERVE, 1996, 19 (07) : 912 - 914